A A A

Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Please select the appropriate competition for current information on panel composition.

Note:

For competitions with an LOI stage - panels may be reduced between stages depending on expertise required to review the full applications. Panel members participating in the LOI review only will be marked with an *.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCSRI based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including genomics, proteomics, metabolomics (and other ‘omics’), high-throughput sequencing, bioinformatics, diagnostic, prognostic and predictive biomarkers, circulating tumour cells.

Panel meeting: December 5, 2016

Harriet Feilotter, PhD (Chair) Queen’s University
Kingston, ON
Jane Bayani, PhD Ontario Institute for Cancer Research
Toronto, ON
Nicolas Crapoulet, PhD
Atlantic Cancer Research Institute
Moncton, NB
Andrew Emili, PhD
University of Toronto
Toronto, ON 
Michael Hendzel, PhD  University of Alberta
Edmonton, AB
Thomas Kislinger, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Julian Lum, PhD  BC Cancer Agency
Vancouver, BC
Leigh Murphy, PhD
Manitoba Institute of Cell Biology
Winnipeg, MB
Kirill Rosen, PhD Dalhousie University
Halifax, NS
Robert Sladek, MD McGill University
Montreal, QC
Zhaolin Xu, MD Dalhousie University
Halifax, NS
Gelareh Zadeh, MD/PhD The Toronto Hospital (Western Division) - UHN
Toronto, ON
Hansen He, PhD (Scientific Officer) Princess Margaret Cancer Centre - UHN
Toronto, ON 
Scott Bratman, MD/PhD (Scientific Officer) Princess Margaret Cancer Centre - UHN
Toronto, ON
Tanya Gallant (Community Representative) Canadian Cancer Society - PEI Division 
Mai Tran (Community Representative)  Canadian Cancer Society - Alberta/NWT Division

 

I1b - Gene Regulation & Cell Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: December 8, 2016

Peter Greer, PhD (Chair) Queen's University
Kingston, ON
Kristin Baetz, PhD University of Ottawa
Ottawa, ON
Peter Black, MD University of British Columbia
Vancouver, BC
David Brindley, PhD University of Alberta
Edmonton, AB
Elizabeth Conibear, PhD
University of British Columbia
Vancouver, BC
Richard Fahlman, PhD University of Alberta
Edmonton, AB
Gerardo Ferbeyre, PhD University of Montreal
Montreal, QC
Imed Gallouzi, PhD
McGill University
Montreal, QC 
Anne-Claude Gringas, PhD
Mount Sinai Hospital
Toronto, ON 
Benjamin Kwok, PhD Institute for Research in Immunology and Cancer (IRIC)
Montreal, QC
Mathieu Lupien, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Jane McGlade, PhD The Hospital for Sick Children
Toronto, ON
Gilbert Prive, PhD
University Health Network
Toronto, ON
Uri Tabori, MD The Hospital for Sick Children
Toronto, ON 
Yojiro Yamanaka, PhD McGill University
Montreal, QC
Michael Downey, PhD (Scientific Officer) University of Ottawa
Ottawa, ON 
Paul Kongkham, MD/PhD (Scientific Officer) University Health Network
Toronto, ON
Dawn Ashforth (Community Representative) Canadian Cancer Society - Ontario Division 
John Sterns (Community Representative)  Canadian Cancer Society - Ontario Division

 

I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: December 12, 2016

Aaron Fenster, PhD (Chair) Robarts Research Institute
London, ON
David Juncker, PhD McGill University
Montreal, QC 
Marianna Koritzinsky, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Piotr Kozlowski, PhD
University of British Columbia
Vancouver, BC
Jonathan Lovell, PhD University at Buffalo
Buffalo, NY
Cynthia Menard, MD Centre Hospitalier de l’Universite de Montreal
Montreal, QC
Alan Nichol, MD BC Cancer Agency
Vancouver, BC 
Mark Niedre, PhD Northeastern University
Boston, MA
Christopher Phenix, PhD
University of Saskatoon
Saskatoon, SK
Paul Schaffer, PhD TRIUMF
Vancouver, BC
Shiladitya Sengupta, PhD Brigham and Women's Hospital
Cambridge, MA
Jack Tuszynski, PhD University of Alberta
Edmonton, AB
Kazuhiro Yasufuku, MD/PhD
Toronto General Hospital - UHN
Toronto, ON 
Haishan Zeng, PhD BC Cancer Agency
Vancouver, BC
Gang Zheng, PhD
Princess Margaret Cancer Centre - UHN
Toronto, ON
Christopher Moraes, PhD (Scientific Officer) McGill University
Montreal, QC 
Aaron Ward, PhD (Scientific Officer) London Health Sciences Centre
London, ON 
Sean Nurmsoo (Community Representative)  Canadian Cancer Society - Nova Scotia Division
Yalda Hazrat (Community Representative) Canadian Cancer Society - BC/Yukon Division 

 

I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity and infection, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: December 9, 2016

Jayne Danska, PhD (Chair) The Hospital for Sick Children
Toronto, ON
Ninan Abraham, PhD University of British Columbia
Vancouver, BC
David Brooks, PhD
Princess Margaret Cancer Centre - UHN
Toronto, ON 
David Evans, PhD University of Alberta
Edmonton, AB
Spencer Gibson, PhD
University of Manitoba
Winnipeg, MB
Michael Gold, PhD
University of British Columbia
Vancouver, BC
Norman Iscove, MD/PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Kevin Kane, PhD University of Alberta
Edmonton, AB 
Jean Marshall, PhD Dalhousie University
Halifax, NS
Mark Minden, MD/PhD  Princess Margaret Cancer Centre - UHN
Toronto, ON
Luc Sabourin, PhD Ottawa Hospital Research Institute
Ottawa, ON
Vuk Stambolic, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
William Stanford, PhD Ottawa Hospital Research Institute
Ottawa, ON
David Stojdl, PhD Children's Hospital of Eastern Ontario
Ottawa, ON 
Jacques Thibodeau, PhD  University of Montreal
Montreal, QC 
Patrick O’Donoghue, PhD (Scientific Officer) Western University
London, ON
Jean Wang, MD/PhD (Scientific Officer) Princess Margaret Cancer Centre - UHN
Toronto, ON
Sandy McDonald (Community Representative)  Canadian Cancer Society - Ontario Division 
Genevieve Roussy (Community Representative) Canadian Cancer Society - New Brunswick Division 

 

I4 - Novel Therapeutics

Including drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: December 1, 2016

Craig Thomas, PhD (Chair) National Institutes of Health
Rockville, MD
Philippe Bedard, MD Princess Margaret Cancer Centre - UHN
Toronto, ON
Robert Britton, PhD Simon Fraser University
Burnaby, BC
Daniel De Carvalho, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Mark Glover, PhD University of Alberta
Edmonton, AB
Matthew Hall, PhD National Institutes of Health
Rockville, MD 
Philip Hieter, PhD University of British Columbia
Vancouver, BC
Jose Monzon, MD/PhD Tom Baker Cancer Centre
Calgary, AB
Kevin Petrecca, MD/PhD  McGill University
Montreal, QC 
Lynne-Marie Postovit, PhD  University of Alberta
Edmonton, AB
Michel Roberge, PhD University of British Columbia
Vancouver, BC
Donna Senger, PhD University of Calgary
Calgary, AB
Christian Steidl, MD/PhD
BC Cancer Agency
Vancouver, BC 
Josie Ursini-Siegel, PhD Lady Davis Institute
Montreal, QC
Murray Webb, PhD The Centre for Drug Research and Development (CDRD)
Vancouver, BC
Jeremy Wulff, PhD University of Victoria
Victoria, BC
Rebecca Laposa, PhD (Scientific Officer) University of Toronto
Toronto, ON
Daniel Schramek, PhD (Scientific Officer) Mount Sinai Hospital
Toronto, ON
Nancy McFadden (Community Representative) Canadian Cancer Society - Ontario Division 
Angie Woodcock (Community Representative) Canadian Cancer Society - Ontario Division

 

I5 - Prevention and Quality of Life 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: June 2, 2016

Patricia Parker, PhD (Chair) Memorial Sloan-Kettering Cancer Center
New York, NY
Catherine Alfano, PhD  American Cancer Society
Washington, DC 
Angel Aranout, MD Ottawa Hospital Research Institute
Ottawa, ON 
Lisa Barbera, MD
Sunnybrook Research Institute
Toronto, ON
Hugh Davies, PhD University of British Columbia
Vancouver, BC
Karen Kopciuk, PhD  Alberta Health Services
Calgary, AB 
Jane McCusker, MD/DrPH
McGill University
Montreal, QC
Jennifer O'Loughlin, PhD

University of Montreal
Montreal, QC

Robert Reid, PhD/MBA University of Ottawa Heart Institute
Ottawa, ON
Catherine Sabiston, PhD University of Toronto
Toronto, ON 
Jonathan Sussman, MD Juravinski Cancer Centre
Hamilton, ON
Alice Wei, MD  Princess Margaret Cancer Centre - UHN
Toronto, ON
Jennifer Brunet, PhD (Scientific Officer) University of Ottawa
Ottawa, ON
Brita Danielson, MD (Scientific Officer) Alberta Health Services
Edmonton, AB
Stephen Ng (Community Representative)  Canadian Cancer Society - BC/Yukon Division

 

Impact Grant panel

LOI review teleconference: June 17, 2016

Panel meeting: November 21, 2016

Craig Earle, MD (Co-Chair) Sunnybrook Research Institute
Toronto, ON 
Jim Woodgett, PhD (Co-Chair) Mount Sinai Hospital
Toronto, ON
*Samuel Aparicio, PhD BC Cancer Agency
Vancouver, BC
Jason Berman, MD IWK-Grace Health Centre
Halifax, NS
Mick Bhatia, PhD McMaster University
Hamilton, ON
Deborah Bowen, PhD University of Washington
Seattle, WA
*Grant Brown, PhD University of Toronto
Toronto, ON
Andrew Craig, PhD Queen’s University
Kingston, ON
Shoukat Dedhar, PhD BC Cancer Agency
Vancouver, BC
*Mary Jane Esplen, PhD/RN Princess Margaret Cancer Centre – UHN
Toronto, ON
Steven Gallinger, MD  Mount Sinai Hospital
Toronto, ON 
Trang Hoang, PhD IRIC
Montreal, QC
*Nada Jabado, MD/PhD McGill University
Montreal, QC
*Rama Khokha, PhD  Princess Margaret Cancer Centre – UHN
Toronto, ON 
*Robert Korneluk, PhD Children’s Hospital of Eastern Ontario
Ottawa, ON
*Nathalie Labrecque, PhD University of Montreal
Montreal, QC
*Claude Perreault, MD  IRIC
Montreal, QC 
Geoff Porter, MD Dalhousie University
Halifax, NS
Poul Sorensen, MD/PhD BC Cancer Agency
Vancouver, BC
*Jeffrey Wrana, PhD Mount Sinai Hospital
Toronto, ON
*Li Zhang, MD/PhD Toronto General Hospital – UHN
Toronto, ON
Harold Atkins, MD (Scientific Officer)  Ottawa Hospital Research Institute
Ottawa, ON
Lillian Sung, MD/PhD (Scientific Officer) The Hospital for Sick Children
Toronto, ON
Dawn Ashforth (Community Representative) Canadian Cancer Society - Ontario Division 
Melissa Chan (Community Representative) Canadian Cancer Society - Alberta/NWT Division

Prevention Research Grant panel

LOI review teleconference: April 4, 2016

Panel meeting: September 26, 2016

Eduardo Franco, MPH/PhD (Chair)  McGill University
Montreal, QC
*Irene Andrulis, PhD  Mount Sinai Hospital
Toronto, ON 
*Sunday Azagba, PhD University of Waterloo
Waterloo, ON
Louise Brinton, PhD/MPH National Cancer Institute
Rockville, MD
Michael Chaiton, PhD University of Toronto
Toronto, ON
*Claire de Oliveira, PhD Centre for Addiction and Mental Health
Toronto, ON
*Walter Gotlieb, MD/PhD  Jewish General Hospital
Montreal, QC 
Emmanuel Guindon, PhD McMaster University
Hamilton, ON
Melissa Henry, PhD Jewish General Hospital
Montreal, QC
*Nancy Kreiger, MPH/PhD/FACE University of Toronto
Toronto, ON
Anthony Miller, MD/FACE University of Toronto
Toronto, ON
*Lisa Mirabello, PhD National Cancer Institute
Rockville, MD
*Jennifer O'Loughlin, PhD CRCHUM, University of Montreal
Montreal, QC
*Lawrence Paszat, MD University of Toronto
Toronto, ON
Harriet Richardson, PhD Queen’s University
Kingston, BC
Beti Thompson, PhD Fred Hutchinson Cancer Research Center
Seattle, WA
Amy Yaroch, PhD Gretchen Swanson Center for Nutrition
Omaha, NE
Regina Ziegler, PhD/MPH National Cancer Institute
Rockville, MD 
Geetanjali Datta, PhD (Scientific Officer) University of Montreal
Montreal, QC 
Leia Minaker, PhD (Scientific Officer) University of Waterloo
Waterloo, ON
Janice Hodgson (Community Representative)
Canadian Cancer Society - Ontario Division
Mark Kahan (Community Representative)
Canadian Cancer Society - Alberta/NWT Division

CCS-Partner Prevention Research Grant panel

LOI review teleconference: April 29, 2014

Panel meeting: September 30, 2014

Richard (Dick) Clayton, PhD (Chair)  University of Kentucky
Lexington, KY, USA
Tracie Barnett, PhD  University of Montreal
Montreal, QC 
Ulrike (Uli) Boehmer, PhD  Boston University
Boston, MA, USA 
Anne Leis, PhD University of Saskatchewan
Saskatoon, SK
S. Elizabeth McGregor, PhD  Alberta Health Services
Calgary, AB 
Annette Schultz, PhD/RN  University of Manitoba
Winnipeg, MB 
Siobhan Sutcliffe, PhD  Washington University School of Medicine
St. Louis, MO, USA
Shelley Tworoger, PhD  Harvard University
Boston, MA, USA 
Melanie Keats, PhD (Scientific Officer) Dalhousie University
Halifax, NS 
Sylvie Poissant (End User)  Canadian Cancer Society - Quebec Division
Montreal, QC
Anne McTiernan-Gamble (End User)  Canadian Cancer Society - New Brunswick Division
Saint John, NB
Julie Stratton (End User)  Region of Peel, Public Health
Mississauga, ON

Career Development Awards in Prevention panel

Panel meeting: June 14, 2016

Julia Knight, PhD (Chair)  Mount Sinai Hospital
Toronto, ON
Joan L. Bottorff, PhD/RN University of British Columbia Okanagan
Kelowna, BC
Sean Cleary, MD Mount Sinai Hospital
Toronto, ON
Katherine Frohlich, PhD University of Montreal
Montreal, QC
Sam Harper, MSPH/PhD McGill University
Montreal, QC
Rayjean Hung, PhD Mount Sinai Hospital
Toronto, ON
Young-in Kim, MD University of Toronto
Toronto, ON
Joanne Kotsopoulos, PhD Women’s College Hospital
Toronto, ON
Jennifer Yessis, PhD University of Waterloo
Waterloo, ON

Quality of Life Grant panel

LOI review teleconference: September 13, 2016

Panel meeting: January 12, 2017

Jamie Studts, PhD (Chair) University of Kentucky
Lexington, KY
Natasha Leighl, MD (Chair) Princess Margaret Cancer Centre
Toronto, ON
*Cristina Caperchione, PhD University of British Columbia (Okanagan)
Kelowna, BC
Anees Chagpar, MD Yale University
New Haven, CT
*Kelvin Chan, MD
Sunnybrook Research Institute
Toronto, ON
Winson Cheung, PhD BC Cancer Agency
Vancouver, BC
*Harvey Chochinov, MD/PhD CancerCare Manitoba
Winnipeg, MB
Kristine Donovan, PhD/MBA  Moffitt Cancer Center and Research Institute
Tampa, FL
David Eisenstat, MD University of Alberta
Edmonton, AB 
*Heidi Hamann, PhD University of Arizona
Tucson, AZ
Cheryl Harris, PhD
Ottawa Hospital Research Institute
Ottawa, ON
*Doris Howell, PhD Princess Margaret Cancer Centre
Toronto, ON
*Jennifer Jones, PhD
Princess Margaret Cancer Centre
Toronto, ON
*Kimberly Kelly, PhD
West Virginia University
Morgantown, WV
Sophie Lebel, PhD University of Ottawa
Ottawa, ON
*Christopher Longo, PhD McMaster University
Hamilton, ON
Paul Nathan, MD
The Hospital for Sick Children
Toronto, ON
Gregory Pond, PhD McMaster University
Hamilton, ON
*Tara Schapmire, PhD  University of Louisville
Louisville, KY
Allen Sherman, PhD  University of Arkansas
Little Rock, AR 
James Wright, MD Juravinski Cancer Centre
Hamilton, ON 
 Sarah Hales, MD (Scientific Officer)
Princess Margaret Cancer Centre
Toronto, ON
Patricia Poulin, PhD (Scientific Officer)
Ottawa Hospital Research Institute
Ottawa, ON 
Michelle Sweeney (Community Representative) Canadian Cancer Society - BC/Yukon Division 
Cindy Vinall (Community Representative) Canadian Cancer Society - Ontario Division 

Knowledge to Action Grant panel

Panel meeting: June 20, 2016

David Chambers, PhD (Chair)  National Cancer Institute
Rockville, MD
Smita Banerjee, PhD Memorial Sloan-Kettering Cancer Center
New York, NY 
Arminee Kazanjian, PhD University of British Columbia
Vancouver, BC
Martine Puts, RN/PhD University of Toronto
Toronto, ON
Barbara Riley, PhD University of Waterloo
Waterloo, ON
Brenda Sabo, RN/PhD Dalhousie University
Halifax, NS
Adena Scheer, MD St. Michael's Hospital
Toronto, ON
Marko Simunovic, MD/MPH Juravinski Cancer Centre
Hamilton, ON
Kelli Stajduhar, RN/PhD University of Victoria
Victoria, BC
Sharon Straus, MD University of Toronto
Toronto, ON 
Aisha Lofters, MD/PhD (Scientific Officer) St Michael’s Hospital
Toronto, ON
Jessie-Lee McIsaac, PhD (Scientific Officer)
Dalhousie University
Halifax, NS
Anick Labelle (Community Representative) 
Canadian Cancer Society - Quebec Division
Ryan Normore (Community Representative) 
Canadian Cancer Society - Nova Scotia Division
Ontario Institute for Cancer Research
Toronto, ON
Ontario Institute for Cancer Research
Toronto, ON

Last modified on: November 4, 2016